With new FDA draft guidance, global collaboration pilots, and AI-enabled regulatory processes, agencies are striving to balance innovation with safety, speed, and equitable access. Yet challenges in manufacturing, harmonization, and affordability persist. Explore the opportunities shaping the future of CGT regulation.
Read More